GNMX
Aevi Genomic Medicine, Inc.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Aevi Genomic Medicine, Inc. is a clinical stage biopharmaceutical company, which engages in finding treatments for rare and orphan diseases. Its research and development efforts leverage an internal genomics platform and an ongoing collaboration with the Center for Applied Genomics (CAG) at The Children's Hospital of Philadelphia (CHOP). The company was founded by Andrew Leonard Pearlman on January 27, 2000 and is headquartered in Wayne, PA.
Market Cap: 12.9 Million
Primary Exchange: NASDAQ
Website: http://www.aevigenomics.com
Shares Outstanding: 77.7 Million
Float: 54.4 Million
Dividend: (%)
Beta: 0.9508910804826353
Sector: Health Technology
Industry: Biotechnology
Ethical Flags
Longest drawdown: 1774 trading days
From: 2015-09-18 To: 2020-02-03
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|